(Q77359717)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

F J Bianco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D P Wood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Gomes de Oliveira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J A Nemeth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A A Beaman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M L Cher

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

235-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

Should Gleason score 7 prostate cancer be considered a unique grade category?

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Identification of bone marrow micrometastases in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Prostate. Practice parameters, pathologic staging, and handling radical prostatectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Can Radical Prostatectomy Alter the Progression of Poorly Differentiated Prostate Cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Prognostic significance of positive surgical margins in radical prostatectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Reverse transcriptase-polymerase chain reaction assays for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Detection and clinical importance of micrometastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

Immunocytochemical monitoring of micrometastatic disease: reduction of prostate cancer cells in bone marrow by androgen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10018

21 January 2018

Identifiers

DOI

10.1002/PROS.10018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746269%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference